Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Donovan-Brand

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
International Journal of Immunopharmacology|November 1, 1993
Study of procainamide hapten-specific antibodies in rabbits and humansL E Adams, S M Roberts, R Donovan-Brand, et al.
The Journal of Laboratory and Clinical Medicine|February 1, 1986
Polynucleotide antibodies in connective tissue disease: viral markers or disease mediators?G Spencer-Green, L Kelley, L E Adams, et al.
Arthritis and Rheumatism|February 1, 1992
Serologic evaluation of patients receiving procainamideA B Mongey, R Donovan-Brand, T J Thomas, et al.
Clinical Immunology and Immunopathology|March 1, 1988
Sperm and seminal plasma antibodies in acquired immune deficiency (AIDS) and other associated syndromesL E Adams, R Donovan-Brand, A Friedman-Kien, et al.
The Journal of Laboratory and Clinical Medicine|April 1, 1989
Immunomodulatory effects of procainamide metabolites: their implications in drug-related lupusL E Adams, C E Sanders, R A Budinsky, et al.
International Journal of Immunopharmacology|January 1, 1989
Procainamide hydroxylamine lymphocyte toxicity--I. Evidence for participation by hemoglobinS M Roberts, L E Adams, R Donovan-Brand, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
International Journal of Immunopharmacology|November 1, 1993
Study of procainamide hapten-specific antibodies in rabbits and humansL E Adams, S M Roberts, R Donovan-Brand, et al.
The Journal of Laboratory and Clinical Medicine|February 1, 1986
Polynucleotide antibodies in connective tissue disease: viral markers or disease mediators?G Spencer-Green, L Kelley, L E Adams, et al.
Arthritis and Rheumatism|February 1, 1992
Serologic evaluation of patients receiving procainamideA B Mongey, R Donovan-Brand, T J Thomas, et al.
Clinical Immunology and Immunopathology|March 1, 1988
Sperm and seminal plasma antibodies in acquired immune deficiency (AIDS) and other associated syndromesL E Adams, R Donovan-Brand, A Friedman-Kien, et al.
The Journal of Laboratory and Clinical Medicine|April 1, 1989
Immunomodulatory effects of procainamide metabolites: their implications in drug-related lupusL E Adams, C E Sanders, R A Budinsky, et al.
International Journal of Immunopharmacology|January 1, 1989
Procainamide hydroxylamine lymphocyte toxicity--I. Evidence for participation by hemoglobinS M Roberts, L E Adams, R Donovan-Brand, et al.
Pageof 1